SMARCD1 and glioblastoma: As shown in Fig. 5a, b, d, and e (referred as TMZ 0 μM), differential expression of Smarcd1 exhibited no obvious influence in GBM apoptosis except for the kd-sm group, which had a statistic difference than the kd-nc group of U251 cells (P < 0.05).